Literature DB >> 30551139

Arterial and pulmonary hypertension: risk assessment and current pharmacological and interventional management.

Thomas F Lüscher1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30551139     DOI： 10.1093/eurheartj/ehy824

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.

Authors:  Xue-Liang Zhou; Feng-Jian Huang; Yang Li; Huang Huang; Qi-Cai Wu
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

2.  Validation of the Omron HEM-1040 Blood Pressure Monitor According to the American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 81060-2:2013 Protocol.

Authors:  Hakuo Takahashi; Kanako Saito
Journal:  Vasc Health Risk Manag       Date:  2020-12-29

Review 3.  MicroRNA-34a: the bad guy in age-related vascular diseases.

Authors:  Angela Raucci; Federica Macrì; Stefania Castiglione; Ileana Badi; Maria Cristina Vinci; Estella Zuccolo
Journal:  Cell Mol Life Sci       Date:  2021-10-26       Impact factor: 9.261
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.